rs2229089

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_004628.5(XPC):​c.142C>T​(p.Leu48Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0272 in 1,606,840 control chromosomes in the GnomAD database, including 738 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.021 ( 48 hom., cov: 32)
Exomes 𝑓: 0.028 ( 690 hom. )

Consequence

XPC
NM_004628.5 missense

Scores

17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:10O:1

Conservation

PhyloP100: 0.240

Publications

18 publications found
Variant links:
Genes affected
XPC (HGNC:12816): (XPC complex subunit, DNA damage recognition and repair factor) The protein encoded by this gene is a key component of the XPC complex, which plays an important role in the early steps of global genome nucleotide excision repair (NER). The encoded protein is important for damage sensing and DNA binding, and shows a preference for single-stranded DNA. Mutations in this gene or some other NER components can result in Xeroderma pigmentosum, a rare autosomal recessive disorder characterized by increased sensitivity to sunlight with the development of carcinomas at an early age. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Aug 2017]
XPC Gene-Disease associations (from GenCC):
  • xeroderma pigmentosum group C
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P, Myriad Women’s Health, Genomics England PanelApp
  • xeroderma pigmentosum
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0023067892).
BP6
Variant 3-14173024-G-A is Benign according to our data. Variant chr3-14173024-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 135475.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0212 (3225/152266) while in subpopulation NFE AF = 0.0287 (1949/68008). AF 95% confidence interval is 0.0276. There are 48 homozygotes in GnomAd4. There are 1657 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 48 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
XPCNM_004628.5 linkc.142C>T p.Leu48Phe missense_variant Exon 2 of 16 ENST00000285021.12 NP_004619.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
XPCENST00000285021.12 linkc.142C>T p.Leu48Phe missense_variant Exon 2 of 16 1 NM_004628.5 ENSP00000285021.8

Frequencies

GnomAD3 genomes
AF:
0.0212
AC:
3225
AN:
152148
Hom.:
48
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00490
Gnomad AMI
AF:
0.0493
Gnomad AMR
AF:
0.0172
Gnomad ASJ
AF:
0.00576
Gnomad EAS
AF:
0.000769
Gnomad SAS
AF:
0.0151
Gnomad FIN
AF:
0.0586
Gnomad MID
AF:
0.0190
Gnomad NFE
AF:
0.0287
Gnomad OTH
AF:
0.0191
GnomAD2 exomes
AF:
0.0215
AC:
5095
AN:
236852
AF XY:
0.0224
show subpopulations
Gnomad AFR exome
AF:
0.00438
Gnomad AMR exome
AF:
0.00894
Gnomad ASJ exome
AF:
0.00537
Gnomad EAS exome
AF:
0.000175
Gnomad FIN exome
AF:
0.0564
Gnomad NFE exome
AF:
0.0279
Gnomad OTH exome
AF:
0.0206
GnomAD4 exome
AF:
0.0278
AC:
40465
AN:
1454574
Hom.:
690
Cov.:
31
AF XY:
0.0276
AC XY:
19937
AN XY:
723250
show subpopulations
African (AFR)
AF:
0.00366
AC:
121
AN:
33026
American (AMR)
AF:
0.00956
AC:
414
AN:
43326
Ashkenazi Jewish (ASJ)
AF:
0.00552
AC:
143
AN:
25886
East Asian (EAS)
AF:
0.000101
AC:
4
AN:
39654
South Asian (SAS)
AF:
0.0140
AC:
1195
AN:
85102
European-Finnish (FIN)
AF:
0.0532
AC:
2826
AN:
53136
Middle Eastern (MID)
AF:
0.00853
AC:
49
AN:
5744
European-Non Finnish (NFE)
AF:
0.0309
AC:
34302
AN:
1108660
Other (OTH)
AF:
0.0235
AC:
1411
AN:
60040
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
2113
4226
6338
8451
10564
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1284
2568
3852
5136
6420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0212
AC:
3225
AN:
152266
Hom.:
48
Cov.:
32
AF XY:
0.0223
AC XY:
1657
AN XY:
74444
show subpopulations
African (AFR)
AF:
0.00488
AC:
203
AN:
41566
American (AMR)
AF:
0.0172
AC:
263
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.00576
AC:
20
AN:
3470
East Asian (EAS)
AF:
0.000771
AC:
4
AN:
5188
South Asian (SAS)
AF:
0.0156
AC:
75
AN:
4822
European-Finnish (FIN)
AF:
0.0586
AC:
621
AN:
10598
Middle Eastern (MID)
AF:
0.0170
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
0.0287
AC:
1949
AN:
68008
Other (OTH)
AF:
0.0189
AC:
40
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
166
332
498
664
830
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
40
80
120
160
200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0243
Hom.:
203
Bravo
AF:
0.0175
TwinsUK
AF:
0.0329
AC:
122
ALSPAC
AF:
0.0327
AC:
126
ESP6500AA
AF:
0.00506
AC:
19
ESP6500EA
AF:
0.0287
AC:
236
ExAC
AF:
0.0201
AC:
2424
Asia WGS
AF:
0.00404
AC:
14
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:10Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Jan 23, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Feb 11, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 28146470)

Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Xeroderma pigmentosum, group C Benign:3
Feb 01, 2025
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

not specified Benign:2Other:1
Sep 19, 2013
ITMI
Significance:not provided
Review Status:no classification provided
Collection Method:reference population

Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Dec 10, 2021
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Xeroderma pigmentosum group A Benign:1
Jul 07, 2023
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.076
BayesDel_addAF
Benign
-0.48
T
BayesDel_noAF
Benign
-0.44
CADD
Benign
5.6
DANN
Benign
0.79
DEOGEN2
Benign
0.12
T;T
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.073
N
LIST_S2
Benign
0.45
T;T
MetaRNN
Benign
0.0023
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.8
L;.
PhyloP100
0.24
PrimateAI
Benign
0.22
T
PROVEAN
Benign
-1.3
N;N
REVEL
Benign
0.093
Sift
Benign
0.73
T;T
Sift4G
Benign
0.70
T;T
Vest4
0.026
ClinPred
0.00073
T
GERP RS
1.0
Varity_R
0.019
gMVP
0.030
Mutation Taster
=97/3
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2229089; hg19: chr3-14214524; COSMIC: COSV53208173; API